1-20 of 30
Andrew V. Schally
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Abstract 4620: Exploring the role of GHRH antagonist MIA-602 in overcoming doxorubicin resistance in acute myeloid leukemia

Simonetta I. Gaumond, Joel Costoya, Andrew V. Schally, Joaquin J. Jimenez
Journal: Cancer Research
Cancer Res (2024) 84 (6_Supplement): 4620.
https://doi.org/10.1158/1538-7445.AM2024-4620
Published: 22 March 2024
View article titled, Abstract 4620: Exploring the role of GHRH antagonist MIA-602 in overcoming doxorubicin resistance in acute myeloid leukemia
Journal Articles

Abstract 385: Synergistic effects of MIA-602 and its potential for use in ATRA/ATO Resistant APL

Ravinder S. Chale, Mario Rodriguez, Stephanie M. Almeida, Shelly Sclatter, Anastasia Singaready, Andrew V. Schally, Joaquin J. Jimenez
Journal: Cancer Research
Cancer Res (2023) 83 (7_Supplement): 385.
https://doi.org/10.1158/1538-7445.AM2023-385
Published: 04 April 2023
View article titled, Abstract 385: Synergistic effects of MIA-602 and its potential for use in ATRA/ATO Resistant APL
Journal Articles

Abstract 5317: A novel approach to the treatment of ATRA/ATO resistant acute promyelocytic leukemia

Ravinder S. Chale, Stephanie M. Almeida, Ivan Jozic, Andrew V. Schally, Joaquin J. Jimenez
Journal: Cancer Research
Cancer Res (2022) 82 (12_Supplement): 5317.
https://doi.org/10.1158/1538-7445.AM2022-5317
Published: 15 June 2022
View article titled, Abstract 5317: A novel approach to the treatment of ATRA/ATO resistant acute promyelocytic leukemia
Journal Articles

Abstract 91: Powerful inhibition of human renal cell carcinomas with antagonists of growth hormone-releasing hormone (GHRH): a preclinical study.

Ferenc G. Rick, Andrew Abi-Chaker, Luca Szalontay, Norman L. Block, Gabor Halmos, Mehrdad Nadji, Andrew V. Schally
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 91.
https://doi.org/10.1158/1538-7445.AM2013-91
Published: 15 April 2013
View article titled, Abstract 91: Powerful inhibition of human renal cell carcinomas with antagonists of growth hormone-releasing hormone (GHRH): a preclinical study.
Journal Articles

Abstract 4769: Growth hormone-releasing hormone (GHRH) antagonist attenuates cell motility of human endometrial cancer by down-regulating Twist and N-Cadherin expression.

Hsien-Ming Wu, Andrew V. Schally, Peter C.K. Leung
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 4769.
https://doi.org/10.1158/1538-7445.AM2013-4769
Published: 15 April 2013
View article titled, Abstract 4769: Growth hormone-releasing hormone (GHRH) antagonist attenuates cell motility of human endometrial cancer by down-regulating Twist and N-Cadherin expression.
Journal Articles

Abstract 2125: AN-162, a targeted cytotoxic analog of somatostatin, suppresses growth of human hormone refractory prostate cancers in vitro and in vivo.

Ferenc G. Rick, Andrew Abi-Chaker, Luca Szalontay, Norman L. Block, Gabor Halmos, Andrew V. Schally
Journal: Cancer Research
Cancer Res (2013) 73 (8_Supplement): 2125.
https://doi.org/10.1158/1538-7445.AM2013-2125
Published: 15 April 2013
View article titled, Abstract 2125: AN-162, a targeted cytotoxic analog of somatostatin, suppresses growth of human hormone refractory prostate cancers in vitro and in vivo.
Journal Articles

Targeted therapy of gynecological tumors with cytotoxic peptide analogs

Jörg B. Engel, Michael Teifel, Andrew V. Schally
Journal: Cancer Research
Cancer Res (2006) 66 (8_Supplement): 725.
Published: 15 April 2006
View article titled, Targeted therapy of gynecological tumors with cytotoxic peptide analogs
Journal Articles

Human Malignant Melanomas Express Receptors for Luteinizing Hormone Releasing Hormone Allowing Targeted Therapy with Cytotoxic Luteinizing Hormone Releasing Hormone Analogue

Gunhild Keller, Andrew V. Schally, Timo Gaiser, Attila Nagy, Benjamin Baker, Gabriela Westphal, Gabor Halmos, Jörg B. Engel
Journal: Cancer Research
Cancer Res (2005) 65 (13): 5857–5863.
https://doi.org/10.1158/0008-5472.CAN-04-3816
Published: 01 July 2005
View article titled, Human Malignant Melanomas Express Receptors for Luteinizing Hormone Releasing Hormone Allowing Targeted Therapy with Cytotoxic Luteinizing Hormone Releasing Hormone Analogue
Open the PDF for Human Malignant Melanomas Express Receptors for Luteinizing Hormone Releasing Hormone Allowing Targeted Therapy with Cytotoxic Luteinizing Hormone Releasing Hormone Analogue in another window
Journal Articles

Antagonists of Growth Hormone-Releasing Hormone Inhibit the Proliferation of Experimental Non-Small Cell Lung Carcinoma

Zoltan Szereday, Andrew V. Schally, Jozsef L. Varga, Celia A. Kanashiro, Francine Hebert, Patricia Armatis, Kate Groot, Karoly Szepeshazi, Gabor Halmos, Rebeca Busto
Journal: Cancer Research
Cancer Res (2003) 63 (22): 7913–7919.
Published: 21 November 2003
View article titled, Antagonists of Growth Hormone-Releasing Hormone Inhibit the Proliferation of Experimental Non-Small Cell Lung Carcinoma
Open the PDF for Antagonists of Growth Hormone-Releasing Hormone Inhibit the Proliferation of Experimental Non-Small Cell Lung Carcinoma in another window
Journal Articles

Targeted Cytotoxic Somatostatin Analogue AN-238 Inhibits Somatostatin Receptor-positive Experimental Colon Cancers Independently of Their p53 Status

Karoly Szepeshazi, Andrew V. Schally, Gabor Halmos, Patricia Armatis, Francine Hebert, Baodong Sun, Anita Feil, Hippokratis Kiaris, Attila Nagy
Journal: Cancer Research
Cancer Res (2002) 62 (3): 781–788.
Published: 01 February 2002
View article titled, Targeted Cytotoxic Somatostatin Analogue AN-238 Inhibits Somatostatin Receptor-positive Experimental Colon Cancers Independently of Their p53 Status
Open the PDF for Targeted Cytotoxic Somatostatin Analogue AN-238 Inhibits Somatostatin Receptor-positive Experimental Colon Cancers Independently of Their p53 Status in another window
Journal Articles

Regulation of Targeted Chemotherapy with Cytotoxic Lutenizing Hormone-releasing Hormone Analogue by Epidermal Growth Factor

Linda J. Krebs, Xiaopeng Wang, Haridas E. Pudavar, Earl J. Bergey, Andrew V. Schally, Attila Nagy, Paras N. Prasad, Charles Liebow
Journal: Cancer Research
Cancer Res (2000) 60 (15): 4194–4199.
Published: 01 August 2000
View article titled, Regulation of Targeted Chemotherapy with Cytotoxic Lutenizing Hormone-releasing Hormone Analogue by Epidermal Growth Factor
Open the PDF for Regulation of Targeted Chemotherapy with Cytotoxic Lutenizing Hormone-releasing Hormone Analogue by Epidermal Growth Factor in another window
Journal Articles

Inhibition of Metastatic Renal Cell Carcinomas Expressing Somatostatin Receptors by a Targeted Cytotoxic Analogue of Somatostatin AN-238

Artur Plonowski, Andrew V. Schally, Attila Nagy, Hippokratis Kiaris, Francine Hebert, Gabor Halmos
Journal: Cancer Research
Cancer Res (2000) 60 (11): 2996–3001.
Published: 01 June 2000
View article titled, Inhibition of Metastatic Renal Cell Carcinomas Expressing Somatostatin Receptors by a Targeted Cytotoxic Analogue of Somatostatin AN-238
Open the PDF for Inhibition of Metastatic Renal Cell Carcinomas Expressing Somatostatin Receptors by a Targeted Cytotoxic Analogue of Somatostatin AN-238 in another window
Journal Articles

Inhibition of PC-3 Human Androgen-independent Prostate Cancer and Its Metastases by Cytotoxic Somatostatin Analogue AN-238

Artur Plonowski, Andrew V. Schally, Attila Nagy, Baodong Sun, Karoly Szepeshazi
Journal: Cancer Research
Cancer Res (1999) 59 (8): 1947–1953.
Published: 15 April 1999
View article titled, Inhibition of PC-3 Human Androgen-independent Prostate Cancer and Its Metastases by Cytotoxic Somatostatin Analogue AN-238
Open the PDF for Inhibition of PC-3 Human Androgen-independent Prostate Cancer and Its Metastases by Cytotoxic Somatostatin Analogue AN-238 in another window
Journal Articles

Targeted Cytotoxic Analogue of Somatostatin AN-238 Inhibits Growth of Androgen-independent Dunning R-3327-AT-1 Prostate Cancer in Rats at Nontoxic Doses

Miklos Koppan, Attila Nagy, Andrew V. Schally, Jose M. Arencibia, Artur Plonowski, Gabor Halmos
Journal: Cancer Research
Cancer Res (1998) 58 (18): 4132–4137.
Published: 01 September 1998
View article titled, Targeted Cytotoxic Analogue of Somatostatin AN-238 Inhibits Growth of Androgen-independent Dunning R-3327-AT-1 Prostate Cancer in Rats at Nontoxic Doses
Open the PDF for Targeted Cytotoxic Analogue of Somatostatin AN-238 Inhibits Growth of Androgen-independent Dunning R-3327-AT-1 Prostate Cancer in Rats at Nontoxic Doses in another window
Journal Articles

Enzymatic Activation of a Doxorubicin-Peptide Prodrug by Prostate-Specific Antigen

Samuel R. Denmeade, Attila Nagy, Jin Gao, Hans Lilja, Andrew V. Schally, John T. Isaacs
Journal: Cancer Research
Cancer Res (1998) 58 (12): 2537–2540.
Published: 01 June 1998
View article titled, Enzymatic Activation of a Doxorubicin-Peptide Prodrug by Prostate-Specific Antigen
Open the PDF for Enzymatic Activation of a Doxorubicin-Peptide Prodrug by Prostate-Specific Antigen in another window
Journal Articles

Characterization of Bombesin/Gastrin-releasing Peptide Receptors in Human Breast Cancer and Their Relationship to Steroid Receptor Expression

Gabor Halmos, James L. Wittliff, Andrew V. Schally
Journal: Cancer Research
Cancer Res (1995) 55 (2): 280–287.
Published: 01 January 1995
View article titled, Characterization of Bombesin/Gastrin-releasing Peptide Receptors in Human Breast Cancer and Their Relationship to Steroid Receptor Expression
Open the PDF for Characterization of Bombesin/Gastrin-releasing Peptide Receptors in Human Breast Cancer and Their Relationship to Steroid Receptor Expression in another window
Journal Articles

Somatostatin Analogues and Bombesin/Gastrin-releasing Peptide Antagonist RC-3095 Inhibit the Growth of Human Glioblastomas in Vitro and in Vivo

Jacek Pinski, Andrew V. Schally, Gabor Halmos, Karoly Szepeshazi, Kate Groot
Journal: Cancer Research
Cancer Res (1994) 54 (22): 5895–5901.
Published: 01 November 1994
View article titled, Somatostatin Analogues and Bombesin/Gastrin-releasing Peptide Antagonist RC-3095 Inhibit the Growth of Human Glioblastomas <em>in Vitro</em> and <em>in Vivo</em>
Open the PDF for Somatostatin Analogues and Bombesin/Gastrin-releasing Peptide Antagonist RC-3095 Inhibit the Growth of Human Glioblastomas <em>in Vitro</em> and <em>in Vivo</em> in another window
Journal Articles

Inhibitory Effect of Bombesin Receptor Antagonist RC-3095 on the Growth of Human Pancreatic Cancer Cells in Vivo and in Vitro

Yunfeng Qin, Tibor Ertl, Ren-Zhi Cai, Gabor Halmos, Andrew V. Schally
Journal: Cancer Research
Cancer Res (1994) 54 (4): 1035–1041.
Published: 01 February 1994
View article titled, Inhibitory Effect of Bombesin Receptor Antagonist RC-3095 on the Growth of Human Pancreatic Cancer Cells <em>in Vivo</em> and <em>in Vitro</em>
Open the PDF for Inhibitory Effect of Bombesin Receptor Antagonist RC-3095 on the Growth of Human Pancreatic Cancer Cells <em>in Vivo</em> and <em>in Vitro</em> in another window
Journal Articles

Inhibitory Effects of Somatostatin Analogue RC-160 and Bombesin/Gastrin-releasing Peptide Antagonist RC-3095 on the Growth of the Androgen-independent Dunning R-3327-AT-1 Rat Prostate Cancer

Jacek Pinski, Herta Reile, Gabor Halmos, Kate Groot, Andrew V. Schally
Journal: Cancer Research
Cancer Res (1994) 54 (1): 169–174.
Published: 01 January 1994
View article titled, Inhibitory Effects of Somatostatin Analogue RC-160 and Bombesin/Gastrin-releasing Peptide Antagonist RC-3095 on the Growth of the Androgen-independent Dunning R-3327-AT-1 Rat Prostate Cancer
Open the PDF for Inhibitory Effects of Somatostatin Analogue RC-160 and Bombesin/Gastrin-releasing Peptide Antagonist RC-3095 on the Growth of the Androgen-independent Dunning R-3327-AT-1 Rat Prostate Cancer in another window
Journal Articles

High Affinity Binding and Direct Antiproliferative Effects of LHRH Analogues in Human Ovarian Cancer Cell Lines

Günter Emons, Olaf Ortmann, Martin Becker, Gabriele Irmer, Beate Springer, Robert Laun, Fritz Hölzel, Klaus-Dieter Schulz, Andrew V. Schally
Journal: Cancer Research
Cancer Res (1993) 53 (22): 5439–5446.
Published: 01 November 1993
View article titled, High Affinity Binding and Direct Antiproliferative Effects of LHRH Analogues in Human Ovarian Cancer Cell Lines
Open the PDF for High Affinity Binding and Direct Antiproliferative Effects of LHRH Analogues in Human Ovarian Cancer Cell Lines in another window